Brief: Cosmo Pharmaceuticals Strengthens Partnership With RedHill Biopharma
18/02/2021 06:11
Feb 18 (Reuters) - COSMO PHARMACEUTICALS NV COPN.S :
* STRENGTHENS PARTNERSHIP WITH REDHILL BIOPHARMA WITH
MANUFACTURING AGREEMENT FOR MOVANTIK, RHB-204 AND OPAGANIB
Source text - https://bit.ly/3k6mjCP
Further company coverage: COPN.S
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 6600;))
Recent news on Cosmo NV
See all newsFocus: Beyond the Scale: Men turn to cosmetic clinics to complete weight-loss transformation
Ireland's Cosmo recurring revenue rises on winlevi growth, reaffirms FY guidance
Brief: Cosmo Pharmaceuticals H1 EPS EUR -0.279
Cosmo Pharma's male hair loss treatment shows sustained hair growth in year‑long study
Europe Research Roundup: Airbus ,Bechtle, Salzgitter